Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-25

Clinical Trial Update: A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome [Phase 3]

View source ↗

Summary

This clinical trial update reports on a Phase 3 study evaluating the efficacy and safety of transdermal rotigotine in adults with idiopathic Restless Legs Syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotigotine (Neupro) (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED